The panel includes a lipid panel, a comprehensive metabolic panel (CMP), and a hemoglobin A1c (HbA1c) panel: Lipid panel : establishes baseline cholesterol and triglycerides to track cardiovascular-related changes during GLP-1 treatment [4] Comprehensive metabolic panel (CMP) : evaluates 14 biomarkers related to organ function, electrolytes, and metabolic health to get a baseline for monitoring the drugs effectiveness and potential side effects like dehydration [5] Hemoglobin A1c (HbA1c) : measures average blood sugar over 23 months to assess long-term glucose control and guide diabetes-related treatment decisions [6] Together, these tests provide baseline metabolic and cardiovascular information that helps Levity providers safely prescribe and monitor GLP1 medications for weight management
Make sure to keep a close eye on your blood sugar levels as recommended by your semaglutide provider
Still, healthcare professionals may recommend taking these drugs together, at least for a short period, to help kickstart weight loss
Not sure when to use them
The larger point is this: Obesity is increasingly being treated like a medical condition that deserves treatment
made it so it was basically painless